ADIPOQ and Hypercholesterolemia: Thus, OEA-DS, modulating the activity of adiponectin, in combination with its expressed anti-inflammatory effect, may be particularly relevant in the complex therapy of MASLD, especially if this pathology is associated with such metabolic complications as obesity and hypercholesterolemia.